TWiST analysis to estimate overall benefit for metastatic renal cell carcinoma (mRCC) patients (pts) treated in a phase III trial of sunitinib versus interferon-alfa (IFN-alpha) Meeting Abstract

  

Authors:	Patil, S.; Figlin, R. A.; Hutson, T. E.; Michaelson, D.; Negrier, S.; Kim, S. T.; Huang, X.; Motzer, R. J.
Abstract Title:	TWiST analysis to estimate overall benefit for metastatic renal cell carcinoma (mRCC) patients (pts) treated in a phase III trial of sunitinib versus interferon-alfa (IFN-alpha)
Meeting Title:	46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	28
Issue:	15 Suppl.
Meeting Dates:	2010 Jun 4-8
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2010-05-20
Start Page:	365s
Language:	English
ACCESSION:	WOS:000208852003717
DOI:	10.1200/jco.2010.28.15_suppl.4594
PROVIDER:	wos
Notes:	Meeting Abstract: 4594 -- S -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129542